PAUL S COHEN
Allopathic & Osteopathic Physicians|Internal Medicine SYRACUSE, NY NPI 1962490656
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NY Novo Nordisk AS All categories
General Payments — all program years on this page
$3,465.16
- Category: General Payments
- Program years: PY2018–2023
- Record count: 241
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $155.58 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $155.58 | 9 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $35.69 | 2 |
| GlaxoSmithKline, LLC. | $34.37 | 2 |
| PFIZER INC. | $30.54 | 2 |
| ABBVIE INC. | $23.33 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.13 | 1 |
| Lilly USA, LLC | $14.52 | 1 |
By program year
Records — PY2023 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1001661618 | Novo Nordisk Inc | $15.91 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1001661629 | Novo Nordisk Inc | $19.78 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1002710693 | GlaxoSmithKline, LLC. | $20.06 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1002710705 | GlaxoSmithKline, LLC. | $14.31 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1032047521 | Lilly USA, LLC | $14.52 | 01/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1049329811 | PFIZER INC. | $14.49 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1050535445 | PFIZER INC. | $16.05 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 996477663 | Boehringer Ingelheim Pharmaceuticals, Inc. | $17.13 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 996482357 | AbbVie Inc. | $23.33 | 06/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.